I am on a newer weight loss drug. Should I Take a Supplement?

The excitement surrounding the arrival of newer weight loss drugs was an understatement. These drugs – including semaglutide (Wegovy, Ozempic), which are GLP-1 receptor agonists, and tirzepatide (Zepbound, Mounjaro), which are GLP-1 and GIP receptor agonists – are extremely effective for weight loss, as so it’s no wonder why.

For example, in a 2023 meta-analysis of 41 trials and more than 15,000 participants with obesity or overweight but no diabetes, GLP-1 receptor agonists were associated with reduced body weight, body mass index (BMI), and waist circumference compared with control groups. These drugs may cause more insulin release, slower stomach emptying, and decreased appetite. There is also research that suggests GLP-1s reduce “food noise,” a term that refers to intrusive thoughts about food. When you are paying less attention to food, you may not eat as much.

In addition to loss of appetite, nausea, vomiting, and diarrhea may result from the drug, and these factors can definitely influence what and how much you are eating. This in turn increases the risk of nutrient deficiencies, which begs the question: Is it prudent to add a supplement to your regimen if you are on a newer weight loss drug?

We spoke to two registered dietitians to find out.

Leave a Reply

Your email address will not be published. Required fields are marked *